Bletilla striata polysaccharides ameliorate metabolic-associated fatty liver disease by decreasing the NLRP3 inflammasome and pyroptosis
BSP-1 may represent a promising therapeutic agent for MASLD treatment by inhibiting the NLRP3/caspase-1/GSDMD signaling pathway.
Authors
- Xiaojie Wu (ORCID: https://orcid.org/0000-0001-6897-5910)
- Juan Xue (ORCID: https://orcid.org/0000-0003-1534-7632)
- Wenqian Tang
- Yang Fan (ORCID: https://orcid.org/0000-0001-8695-7054)
- Lei Luo (ORCID: https://orcid.org/0000-0002-2163-4614)
- Tingting Yu (ORCID: https://orcid.org/0000-0002-4158-4220)
Institutions
- Hubei University of Chinese Medicine (CN)
- Hubei Provincial Hospital of Traditional Chinese Medicine (CN)
- Integrated Chinese Medicine (China) (HK)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-06-20
- DOI
- https://doi.org/10.3389/fphar.2025.1563275
- Primary Topic
- Biological and pharmacological studies of plants
- Type
- article
- Field-Weighted Citation Impact
- 0.00